"We find that most JAK2 mutations some TP53 mutations and rare KRAS mutations detected in cfDNA are derived from clonal hematopoiesis CH not tumor. Clinicians ordering plasma genotyping must be prepared for the possibility that mutations detected in plasma particularly in genes mutated in CH may not represent true tumor genotype."xsd:string